End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
93.3 TWD | 0.00% | -0.53% | -11.56% |
02/05 | PharmaEngine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
24/04 | PharmaEngine, Inc. Announces First Patient Dosed in Phase I Trial of PEP07 for Solid Tumors | CI |
Evolution of the average Target Price on PharmaEngine, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- 4162 Stock
- Consensus PharmaEngine, Inc.